Daniel S. Curado

HTA/HEOR Consultant
Ministry of Health of Brazil

Presentation(s):

• L-2J - Cost-utility of Nivolumab for Treatment of Head and Neck Cancer from a Brazilian Public Health System Perspective

  Monday, August 23, 2021
  6:30 PM – 7:30 PM US Eastern Time